270 related articles for article (PubMed ID: 17920819)
1. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia.
Strålin K
Int J Antimicrob Agents; 2008 Jan; 31(1):3-11. PubMed ID: 17920819
[TBL] [Abstract][Full Text] [Related]
2. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia.
Skerrett SJ
Semin Respir Infect; 1997 Dec; 12(4):308-21. PubMed ID: 9436958
[TBL] [Abstract][Full Text] [Related]
4. Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores.
Strålin K; Olcén P; Törnqvist E; Holmberg H
Scand J Infect Dis; 2010 Jul; 42(6-7):426-34. PubMed ID: 20141490
[TBL] [Abstract][Full Text] [Related]
5. The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques.
Manali E; Papadopoulos A; Tsiodras S; Polychronopoulos V; Giamarellou H; Kanellakopoulou K
Scand J Infect Dis; 2008; 40(4):286-92. PubMed ID: 17918018
[TBL] [Abstract][Full Text] [Related]
6. Value of rapid aetiological diagnosis in optimization of antimicrobial treatment in bacterial community acquired pneumonia.
Mareković I; Plecko V; Boras Z; Pavlović L; Budimir A; Bosnjak Z; Puretić H; Zele-Starcević L; Kalenić S
Coll Antropol; 2012 Jun; 36(2):401-8. PubMed ID: 22856222
[TBL] [Abstract][Full Text] [Related]
7. Culture versus polymerase chain reaction for the etiologic diagnosis of community-acquired pneumonia in antibiotic-pretreated pediatric patients.
Deng J; Zheng Y; Zhao R; Wright PF; Stratton CW; Tang YW
Pediatr Infect Dis J; 2009 Jan; 28(1):53-5. PubMed ID: 19034066
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)].
Rev Clin Esp; 1999 Nov; 199(11):700-4. PubMed ID: 10638232
[TBL] [Abstract][Full Text] [Related]
9. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
Segreti J; House HR; Siegel RE
Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
[TBL] [Abstract][Full Text] [Related]
10. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.
van der Eerden MM; Vlaspolder F; de Graaff CS; Groot T; Bronsveld W; Jansen HM; Boersma WG
Thorax; 2005 Aug; 60(8):672-8. PubMed ID: 16061709
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization.
Rosón B; Carratalà J; Verdaguer R; Dorca J; Manresa F; Gudiol F
Clin Infect Dis; 2000 Oct; 31(4):869-74. PubMed ID: 11049763
[TBL] [Abstract][Full Text] [Related]
12. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW
Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644
[TBL] [Abstract][Full Text] [Related]
13. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
[TBL] [Abstract][Full Text] [Related]
14. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
15. [What is new in the treatment of community-acquired pneumonia?].
Welte T; Marre R; Suttorp N;
Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
[TBL] [Abstract][Full Text] [Related]
16. Fastidious intracellular bacteria as causal agents of community-acquired pneumonia.
Lamoth F; Greub G
Expert Rev Anti Infect Ther; 2010 Jul; 8(7):775-90. PubMed ID: 20586563
[TBL] [Abstract][Full Text] [Related]
17. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.
Schouten JA; Prins JM; Bonten MJ; Degener J; Janknegt RE; Hollander JM; Jonkers RE; Wijnands WJ; Verheij TJ; Sachs AP; Kullberg BJ;
Neth J Med; 2005 Sep; 63(8):323-35. PubMed ID: 16186645
[TBL] [Abstract][Full Text] [Related]
18. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.
Waterer GW; Wunderink RG
Respir Med; 2001 Jan; 95(1):78-82. PubMed ID: 11207022
[TBL] [Abstract][Full Text] [Related]
19. [Microbiologic diagnosis of community-acquired pneumonia in adults].
Jiménez P P; Calvo A M
Rev Chilena Infectol; 2005; 22 Suppl 1():s32-8. PubMed ID: 16163417
[TBL] [Abstract][Full Text] [Related]
20. Aetiology and resistance patterns of community-acquired pneumonia in León, Nicaragua.
Matute AJ; Brouwer WP; Hak E; Delgado E; Alonso E; Hoepelman IM
Int J Antimicrob Agents; 2006 Nov; 28(5):423-7. PubMed ID: 17046211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
